Senior Director, Controller

About the role

The Senior Director, Controller is a leadership position with broad organizational impact with responsibility for overseeing the company’s global accounting operations, supporting internal and external financial reporting, and supporting the internal control environment. This role ensures the integrity of financial information, compliance with U.S. GAAP and applicable regulatory requirements, and supports strategic decision-making. The Senior Director, Controller is instrumental in driving operational excellence, automation, and scalability within the finance function.

What you'll do

• Lead the accounting function, including general ledger, revenue recognition, accounts payable/receivable, payroll, fixed assets and consolidations.
• Ensure timely and accurate monthly, quarterly, and year-end financial close processes and reporting.
• Support financial reporting, including the preparation of internal and external financial statements in compliance with GAAP, DK GAAP and SEC regulations, as applicable.
• Support a strong internal control environment by maintaining and enhancing internal control over financial reporting (ICOFR) over general ledger activities.
• Provide financial analysis and insights that support strategic business decisions and the long-range planning process.
• Coordinate with external auditors for the annual audit and manage related inquiries and deliverables.
• Assist in the development of technical accounting guidance and in the implementation of new standards.
• Lead and develop a high-performing accounting team; promote continuous learning, cross-training and career development.
• Evaluate and implement systems and process improvements to streamline operations, enhance reporting capabilities and promote efficient cross-functional collaboration.
• Collaborate with FP&A, tax, treasury, legal, and business unit leaders to ensure alignment and effective communication of financial data.
• Support M&A due diligence and integration efforts as needed

Qualifications

• Bachelor’s degree in Accounting, Finance, or related field required.
• Certified Public Accountant (CPA) designation required.
• 10+ years of progressive experience in accounting and financial leadership roles within the biopharma industry in development and commercial stage public companies.
• Public accounting experience (Big 4 or large regional firm) combined with corporate accounting experience within a public biopharma company preferred.
• Solid understanding of U.S. GAAP, DK GAAP (or IFRS), COSO internal control framework, and financial reporting.
• Strong leadership, team development, and communication skills.
• Experience with ERP systems (e.g., MS Dynamics Business Central, Oracle NetSuite, or similar) and other report writer and/or FP&A software a plus.
• Ability to lead change, manage complexity, and drive process improvements in a dynamic environment.
• Monthly travel may be required (up to 20%).
  
  

Equal Employment Opportunity Statement

Zevra is an equal opportunity employer that is committed to diversity and inclusion in the workplace. We prohibit discrimination and harassment of any kind based on race, color, sex, religion, sexual orientation, national origin, disability, genetic information, pregnancy, or any other protected characteristic as outlined by federal, state, or local laws.

Notice to External Recruiters
Zevra does not accept unsolicited resumes from agencies or search firms. Recruiters are requested not to contact employees or hiring managers. All candidate submissions must be coordinated through our Human Resources team and require a prior written agreement. Any resumes sent without such an agreement will not create any implied obligation.

About Zevra Therapeutics, Inc.

We are a rare disease therapeutics company leading with science to make life-changing therapeutics available to patients with significant unmet needs. We involve key thought leaders, physicians, patients, care partners, and advocacy groups in all of our clinical and regulatory development strategies.

With a keen understanding that drug development often requires creative solutions, we have the insight and expertise to forge new pathways to success that others have missed. By following the data without bias, our transparent narratives and common-sense perspective have successfully overcome complex development challenges to make much-needed therapies available to patients.

Nimble and dauntless, we push boundaries beyond what is thought to be possible and advance new therapies that have the potential to bring meaningful improvement to patients’ lives.